The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice-Reference-Cited by-同舟云学术

The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice

Published:2016-09-09 Issue:12 Volume:59 Page:2645-2653
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Casteras Sylvie,Abdul-Wahed Aya,Soty Maud,Vulin Fanny,Guillou Hervé,Campana Mélanie,Le Stunff Hervé,Pirola Luciano,Rajas Fabienne,Mithieux Gilles,Gautier-Stein Amandine

Funder

IFR62 Lyon-Est

Fondation pour la Recherche Médicale

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-016-4097-y.pdf

Reference50 articles.

1. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871

2. Peyrou M, Bourgoin L, Poher A-L et al (2015) Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. J Hepatol 62:421–429

3. Benhamed F, Denechaud PD, Lemoine M et al (2012) The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest 122:2176–2194

4. Stefan N, Häring H-U (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9:144–152

5. Monetti M, Levin MC, Watt MJ et al (2007) Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6:69–78

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity;Scientific Reports;2024-05-11

2. Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with Obesity;2023-11-15

3. Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus;International Journal of Molecular Sciences;2023-03-01

4. Studies on glycogen storage disease type 1a animal models: a brief perspective;Transgenic Research;2022-08-25

5. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human;Frontiers in Endocrinology;2020-12-22